Prognosis

Oxford to Resume Trial of AstraZeneca Vaccine

Study restarts after halt to assess participant’s illness
No word from Astra or Oxford on status of separate U.S. trial

First Word: AstraZeneca Resumes U.K. Vaccine Trial

Have a confidential tip for our reporters? Get in Touch

Before it’s here, it’s on the Bloomberg Terminal

LEARN MORE

By Stephanie Baker

September 12, 2020 at 9:23 AM EDT

Updated on

September 12, 2020 at 4:30 PM EDT

This article is for subscribers only.

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

The University of Oxford and AstraZeneca Plc have restarted a U.K. trial of an experimental Covid-19 vaccine after it was halted over concerns about a participant who fell ill.

Have a confidential tip for our reporters? Get in Touch

Before it’s here, it’s on the Bloomberg Terminal

LEARN MORE